Truist Financial’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $864K | Sell |
12,225
-3,051
| -20% | -$165K | ﹤0.01% | 1865 |
|
|
2026
Q1 | $798K | Buy |
15,276
+409
| +3% | +$24.6K | ﹤0.01% | 1828 |
|
|
2025
Q4 | $874K | Sell |
14,867
-575
| -4% | -$34.9K | ﹤0.01% | 1735 |
|
|
2025
Q3 | $859K | Sell |
15,442
-2,229
| -13% | -$119K | ﹤0.01% | 1749 |
|
|
2025
Q2 | $909K | Buy |
17,671
+3,060
| +21% | +$154K | ﹤0.01% | 1642 |
|
|
2025
Q1 | $857K | Sell |
14,611
-5,394
| -27% | -$366K | ﹤0.01% | 1595 |
|
|
2024
Q4 | $1.44M | Sell |
20,005
-856
| -4% | -$62.9K | ﹤0.01% | 1392 |
|
|
2024
Q3 | $1.67M | Sell |
20,861
-499
| -2% | -$37.5K | ﹤0.01% | 1310 |
|
|
2024
Q2 | $1.53M | Sell |
21,360
-479
| -2% | -$35.3K | ﹤0.01% | 1400 |
|
|
2024
Q1 | $1.54M | Buy |
21,839
+895
| +4% | +$64K | ﹤0.01% | 1413 |
|
|
2023
Q4 | $1.62M | Buy |
20,944
+867
| +4% | +$57.1K | ﹤0.01% | 1372 |
|
|
2023
Q3 | $1.37M | Buy |
20,077
+1,786
| +10% | +$141K | ﹤0.01% | 1424 |
|
|
2023
Q2 | $1.49M | Sell |
18,291
-2,597
| -12% | -$209K | ﹤0.01% | 1389 |
|
|
2023
Q1 | $1.55M | Sell |
20,888
-5,794
| -22% | -$447K | ﹤0.01% | 1346 |
|
|
2022
Q4 | $2.21M | Buy |
26,682
+202
| +0.8% | +$16K | ﹤0.01% | 1164 |
|
|
2022
Q3 | $1.88M | Sell |
26,480
-1,400
| -5% | -$121K | ﹤0.01% | 1209 |
|
|
2022
Q2 | $2.42M | Sell |
27,880
-4,004
| -13% | -$375K | ﹤0.01% | 1117 |
|
|
2022
Q1 | $3.45M | Sell |
31,884
-292
| -0.9% | -$30.1K | 0.01% | 1031 |
|
|
2021
Q4 | $4.16M | Buy |
32,176
+5,324
| +20% | +$653K | 0.01% | 959 |
|
|
2021
Q3 | $3.25M | Sell |
26,852
-2,152
| -7% | -$262K | 0.01% | 1050 |
|
|
2021
Q2 | $3.27M | Sell |
29,004
-348
| -1% | -$36.6K | 0.01% | 1060 |
|
|
2021
Q1 | $2.8M | Buy |
29,352
+612
| +2% | +$55.8K | ﹤0.01% | 1083 |
|
|
2020
Q4 | $2.28M | Sell |
28,740
-4,000
| -12% | -$290K | ﹤0.01% | 1118 |
|
|
2020
Q3 | $2.03M | Buy |
32,740
+3,224
| +11% | +$210K | ﹤0.01% | 1064 |
|
|
2020
Q2 | $1.95M | Buy |
29,516
+3,920
| +15% | +$235K | ﹤0.01% | 1042 |
|
|
2020
Q1 | $1.21M | Buy |
25,596
+240
| +0.9% | +$12K | ﹤0.01% | 1184 |
|
|
2019
Q4 | $1.39M | Buy |
25,356
+17,204
| +211% | +$903K | ﹤0.01% | 1297 |
|
|
2019
Q3 | $399K | Sell |
8,152
-160
| -2% | -$8.02K | 0.01% | 604 |
|
|
2019
Q2 | $433K | Sell |
8,312
-680
| -8% | -$34.3K | 0.01% | 606 |
|
|
2019
Q1 | $446K | Hold |
8,992
| – | – | 0.01% | 592 |
|
|
2018
Q4 | $325K | Buy |
8,992
+4,400
| +96% | +$184K | 0.01% | 627 |
|
|
2018
Q3 | $234K | Buy |
+4,592
| New | +$203K | ﹤0.01% | 723 |
|
Other funds holding TECH
HI
Truist Financial's TECH Position: Q2 2026 in Review
Truist Financial reduced its Bio-Techne (TECH) stake by 20% in Q2 2026, selling an estimated $165K and leaving 12,225 shares worth $864K. The position accounts for ﹤0.01% of the portfolio, ranked #1865.
Truist Financial first reported a position in TECH in Q3 2018 and has held it in 32 quarters since. The position peaked at $4.16M in Q4 2021. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.
- Truist Financial held 12,225 shares of Bio-Techne worth $864K as of Q2 2026.
- Truist Financial sold 3,051 Bio-Techne shares in Q2 2026, an estimated $165K.
- Bio-Techne made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #1865 holding.
- Truist Financial first reported a position in Bio-Techne in Q3 2018 and has held it in 32 quarters since.
- Truist Financial's Bio-Techne position peaked at $4.16M in Q4 2021.
- 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.
Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.